2025医疗领域投资白皮书_私募股权投资者调研_20页_3mb

Summary of Stax PE Investor Survey: Healthcare 2025

Core Content

The Stax PE Investor Survey: Healthcare 2025 provides an in-depth analysis of the current state and future outlook of healthcare private equity (PE) investments. The report highlights a mix of optimism and caution among investors, influenced by macroeconomic factors, tariff uncertainty, and evolving market dynamics.

Main Views

• Investor Sentiment:
  Despite tariff-related uncertainty, investor sentiment has strengthened in 2025. About 80% of surveyed healthcare-focused PE investors remain optimistic about deal flow, with 52% expressing high optimism for the remainder of the year.

• Drivers of Increased Deal Activity:
  The primary factors driving increased deal activity in 2025 include:

  • Attractive assets coming to market (70% of respondents)
  • Declining interest rates (53%)
  • Pressure from LPs to return capital (27%)
  • Long hold periods for existing assets (40%)

• Capital Deployment Expectations:
  On average, investors anticipate deploying 6% more healthcare capital in 2025 compared to 2024, with this expectation remaining consistent before and after tariff implementation.

• Tariff Impact:
  Tariffs are expected to have a moderate to minor impact on deal flow, with 48% of investors anticipating only a minor effect and 38% expecting a moderate impact. Asset valuations are expected to rise by about 2% on average, though 70% of investors still anticipate a single-digit valuation increase.

• Thematic Investment Areas:
  The top three thematic areas of focus for healthcare PE investors in 2025 are:

  1. Healthcare Facilities (e.g., SNFs, ASCs, dialysis centers)
  2. Hospital Operations Technology (e.g., scheduling optimization, compliance software)
  3. Retail Health (e.g., urgent care centers)

  Other notable areas include non-physician services (e.g., dental, physical therapy) and pharma tech and outsourced services.

• Due Diligence Considerations:
  Due to tariff uncertainty, investors are increasingly focusing on:

  • Customer pricing sensitivity (86% of respondents)
  • Country of origin tracing (72%)
  • Supply chain analysis (56%)
  • Supplier relationship strength (40%)
  • Inventory contingency planning (30%)
  • CapEx impact from sourcing relocation (28%)

• AI in Healthcare Investment:
  AI is expected to play a significant role in 2025 healthcare deal activity, particularly in:

  • Hospital operations technology
  • Facility optimization
  • Consumer-driven health

  AI is seen as a complementary tool to enhance workflows and improve outcomes, rather than a substitute for human expertise.

• Investor Focus in Specific Areas:

  • Healthcare Facilities: Hospitals and urgent care centers remain a key focus, with technology-driven solutions for compliance, cybersecurity, and capacity management in high demand.
  • Healthcare Services: Retail health and consumer-driven services like medspas are of interest, though reimbursement risk remains a concern.
  • Dental Services: High fragmentation continues to make DSO consolidation an attractive exit strategy.
  • Pharma Tech and Outsourced Services: Clinical trial technology and pharma marketing tech are in focus, especially in oncology, rare disease, and neurology.
  • Physician Practice Management (PPM): Primary care remains the most in-demand area, with a focus on value-based care models.

Key Information

• Survey Sample:
  The survey included 200 respondents, comprising healthcare PE investors with varying fund sizes and titles (e.g., Managing Director, Director, Partner).

• Tariff Impact on Asset Valuations:
  While tariffs have increased sourcing costs, they are not expected to drastically reduce deal activity. Investors are more focused on customer pricing sensitivity than on supply chain or country of origin analysis.

• Stax Healthcare Team:
  Stax has a highly specialized healthcare team with 30+ years of experience, offering strategic and operational expertise to support PE firms throughout the investment lifecycle.

• POTLOC:
  POTLOC is a leading survey platform that provides high-quality data and AI-powered analysis to help firms make informed investment decisions. It has supported over 500 global firms in collecting insights across industries and geographies.

Conclusion

The 2025 healthcare PE investment landscape is characterized by increased deal activity, AI integration, and strategic focus on facilities and technology. While tariffs introduce uncertainty, they are not expected to derail investment momentum. Investors are adopting more rigorous due diligence practices and prioritizing areas with strong growth potential and operational efficiency.